Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Paulus Stoffels
Age : 60
Public asset : 48,152,279 USD
Country of residence : Unknown
Linked companies : Koninklijke Philips N.V. - Galapagos NV

Biography of Paulus Stoffels 
Dr. Paulus Stoffels, MD, is a Vice Chairman-Supervisory Board & Secretary at Koninklijke Philips NV, a Worldwide Chairman-Pharmaceuticals at Janssen Research & Development LLC and a Chief Scientific Officer at Johnson & Johnson. He is on the Board of Directors at Koninklijke Philips NV, Interuniversitair Micro-Electronica Centrum VZW and Crucell NV. Dr. Stoffels was previously employed as a Global Head by Johnson & Johnson Pharmaceutical Research & Development LLC, a Chairman by Tibotec Virco NV, and a Chief Executive Officer by Vircorp, Inc. He also served on the board at Janssen Pharmaceutica NV.


Current positions of Paulus Stoffels 
Holdings of Paulus Stoffels 
Paulus Stoffels : Personal Network 
Most Read News 
11/20Buffett's Berkshire boosts stakes in Japan's five biggest trading houses
RE
12/01Salesforce shares tumble after surprise exit of co-CEO Taylor
RE
11/23Berkshire Hathaway says Warren Buffett donates shares to family charities
RE
11/30Meta's Zuckerberg says some of Elon Musk's Twitter content approach 'might work'
RE
11/30Juventus has no requirement of additional capital, says Exor's Elkann
RE
11/30Interpol confirms red notice for Angolan billionaire Isabel dos Santos
RE
11/22'Boomerang CEOs' don't always work out; Disney hopes this one bucks trend
RE
11/21Musk says Twitter to hold off relaunching blue check verification
RE
11/29Ryanair's O'Leary says industry most optimistic in 25 years
RE
11/25Elon Musk says Twitter's ban on Trump after Capitol attack was 'grave mistake'
RE
More news


© 2022 People and Ownership :   
Paulus Stoffels : Connections 


Latest news about Paulus Stoffels 
11/04Transcript : Galapagos NV, Q3 2022 Earnings Call, Nov 04, 2022
CI
08/05Transcript : Galapagos NV, H1 2022 Earnings Call, Aug 05, 2022
CI
06/22Transcript : Abound Bio, Inc., CellPoint B.V., Galapagos NV - M&A Call
CI
05/10Transcript : Koninklijke Philips N.V. - Shareholder/Analyst Call
CI
05/06Transcript : Galapagos NV, Q1 2022 Earnings Call, May 06, 2022
CI
2021Insider Trends: Insider at Johnson & Johnson Acquires Stock Via Option/Derivative Security Sells Portion to Pay Tax, Buy Trend Intact
MT
More news